๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Recombinant hepatocyte growth factor treatment in a canine model of congenital liver hypoplasia

โœ Scribed by Hedwig S. Kruitwagen; Brigitte Arends; Bart Spee; Bas Brinkhof; Ted S.G.A.M. van den Ingh; Victor P.M.G. Rutten; Louis C. Penning; Tania Roskams; Jan Rothuizen


Book ID
111239527
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
272 KB
Volume
31
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Antifibrogenic effect of a deletion vari
โœ H Yasuda; E Imai; A Shiota; N Fujise; T Morinaga; K Higashio ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 847 KB

which may be modulated by the most potent fibrogenic cyto-Hepatic fibrosis, which may lead to cirrhosis, is associkine, transforming growth factor b 1 (TGF-b 1 ). 5,6 Hepatic fiated with most chronic liver diseases. Current therapies brosis is associated with an activation of lipocytes. 2 In hepatic

Hepatocyte growth factor and Madin-Darby
โœ Balkovetz, Daniel F. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 187 KB ๐Ÿ‘ 1 views

It is becoming increasingly apparent that epithelial cell movement and changes in morphology are central to both development and regeneration of epithelial organs and are involved with pathological processes such as transformation of epithelia to carcinoma and metastasis. Hepatocyte growth factor (H